Status:
COMPLETED
Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture
Lead Sponsor:
Allergopharma GmbH & Co. KG
Conditions:
Grass Pollen Allergy
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
The trial is performed to asses efficacy and safety of a sublingual extract of a six grass pollen mixture
Eligibility Criteria
Inclusion
- Rhinitis, Rhinoconjunctivitis, Positive Rast result to grass pollen, Positive skin prick test to grass pollen, Positive specific provocation to grass pollen,
Exclusion
- Serious chronic diseases, Other perennial allergies
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00264459
Start Date
February 1 2003
End Date
September 1 2011
Last Update
January 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Allergopharma GmbH & Co. KG
Reinbek, Germany, 21465